Geneos Wealth Management’s ProShares S&P MidCap 400 Dividend Aristocrats ETF REGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$583K Sell
6,370
-85
-1% -$7.59K 0.01% 689
2026
Q1
$558K Sell
6,455
-411
-6% -$36.5K 0.01% 659
2025
Q4
$578K Sell
6,866
-11
-0.2% -$923 0.01% 628
2025
Q3
$587K Sell
6,877
-20
-0.3% -$1.69K 0.01% 609
2025
Q2
$562K Buy
6,897
+841
+14% +$67.1K 0.01% 673
2025
Q1
$488K Sell
6,056
-393
-6% -$32K 0.02% 628
2024
Q4
$520K Sell
6,449
-215
-3% -$17.9K 0.02% 574
2024
Q3
$545K Sell
6,664
-182
-3% -$14.3K 0.02% 538
2024
Q2
$504K Sell
6,846
-329
-5% -$24.9K 0.02% 491
2024
Q1
$564K Sell
7,175
-175
-2% -$12.9K 0.03% 471
2023
Q4
$541K Sell
7,350
-642
-8% -$44K 0.03% 469
2023
Q3
$533K Sell
7,992
-155
-2% -$10.9K 0.03% 452
2023
Q2
$572K Sell
8,147
-845
-9% -$58.7K 0.03% 434
2023
Q1
$636K Buy
8,992
+1,293
+17% +$94.1K 0.04% 393
2022
Q4
$551K Buy
7,699
+2,266
+42% +$160K 0.03% 401
2022
Q3
$350K Buy
5,433
+2,500
+85% +$175K 0.02% 463
2022
Q2
$201K Sell
2,933
-100
-3% -$7.01K 0.01% 745
2022
Q1
$219K Buy
3,033
+370
+14% +$26.4K 0.01% 767
2021
Q4
$196K Buy
2,663
+1,067
+67% +$76.5K 0.01% 874
2021
Q3
$109K Buy
1,596
+28
+2% +$1.98K ﹤0.01% 1140
2021
Q2
$112K Buy
1,568
+190
+14% +$13.8K ﹤0.01% 1124
2021
Q1
$100K Buy
1,378
+47
+4% +$3.13K ﹤0.01% 1311
2020
Q4
$93K Sell
1,331
-37
-3% -$2.19K ﹤0.01% 1180
2020
Q3
$71K Hold
1,368
﹤0.01% 1090
2020
Q2
$69K Buy
1,368
+55
+4% +$2.75K ﹤0.01% 1077
2020
Q1
$57K Buy
1,313
+109
+9% +$6.02K ﹤0.01% 1066
2019
Q4
$72K Buy
1,204
+20
+2% +$1.18K ﹤0.01% 1081
2019
Q3
$68K Buy
1,184
+222
+23% +$12.9K ﹤0.01% 1042
2019
Q2
$56K Buy
962
+123
+15% +$7.1K ﹤0.01% 1133
2019
Q1
$47K Buy
839
+40
+5% +$2.22K ﹤0.01% 1180
2018
Q4
$40K Sell
799
-200
-20% -$10.9K ﹤0.01% 1206
2018
Q3
$56K Buy
999
+540
+118% +$30.6K ﹤0.01% 1124
2018
Q2
$25K Sell
459
-250
-35% -$13.5K ﹤0.01% 1359
2018
Q1
$37K Sell
709
-200
-22% -$10.7K ﹤0.01% 1139
2017
Q4
$49K Buy
909
+229
+34% +$12.3K ﹤0.01% 1003
2017
Q3
$35K Hold
680
﹤0.01% 1111
2017
Q2
$34K Buy
680
+520
+325% +$26.8K ﹤0.01% 1088
2017
Q1
$8K Hold
160
﹤0.01% 1566
2016
Q4
$8K Hold
160
﹤0.01% 1509
2016
Q3
$7K Buy
160
+25
+19% +$1.17K ﹤0.01% 1489
2016
Q2
$6K Buy
+135
New +$5.99K ﹤0.01% 1473

Other funds holding REGL

Geneos Wealth Management's REGL Position: Q2 2026 in Review

Geneos Wealth Management reduced its ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) stake by 1.3% in Q2 2026, selling an estimated $7.59K and leaving 6,370 shares worth $583K. The position accounts for 0.01% of the portfolio, ranked #689.

Geneos Wealth Management first reported a position in REGL in Q2 2016 and has held it in 41 quarters since. The position peaked at $636K in Q1 2023. 240 funds tracked by Wall St. Rank hold REGL as of Q2 2026.

  • Geneos Wealth Management held 6,370 shares of ProShares S&P MidCap 400 Dividend Aristocrats ETF worth $583K as of Q2 2026.
  • Geneos Wealth Management sold 85 ProShares S&P MidCap 400 Dividend Aristocrats ETF shares in Q2 2026, an estimated $7.59K.
  • ProShares S&P MidCap 400 Dividend Aristocrats ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #689 holding.
  • Geneos Wealth Management first reported a position in ProShares S&P MidCap 400 Dividend Aristocrats ETF in Q2 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's ProShares S&P MidCap 400 Dividend Aristocrats ETF position peaked at $636K in Q1 2023.
  • 240 funds tracked by Wall St. Rank held ProShares S&P MidCap 400 Dividend Aristocrats ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.